Drug repositioning against COVID-19: a first line treatment

References

• Aguilar, J. S., Rice, M., & Wagner, E. K. (1999). The polysulfonated compound Suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells. Virology, 258(1), 141–151. https://doi.org/10.1006/viro.1999.9723
   PubMed Web of Science ®Google Scholar
• Alarcón, B., Lacal, J. C., Fernández-Sousa, J. M., & Carrasco, L. (1984). Screening for new compounds with antiherpes activity. Antiviral Research, 4(5), 231–244. https://doi.org/10.1016/0166-3542(84)90029-9
   PubMed Web of Science ®Google Scholar
• Al-Kamel, H., & Grundmann, O. (2021). Glycyrrhizin as a potential treatment for the novel coronavirus (COVID-19). Mini Reviews in Medicinal Chemistry, 21(16), 2204-2208. https://doi.org/10.2174/1389557521666210210160237
   Google Scholar
• Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., Tenson, T., Kantele, A., & Kainov, D. E. (2020). Discovery and development of safe-in-man broad-spectrum antiviral agents. International Journal of Infectious Diseases, 93, 268–276. https://doi.org/10.1016/j.ijid.2020.02.018
   PubMed Web of Science ®Google Scholar
• Assaad, H. S., & Assaad-Khalil, S. (2020). Imatinib a Tyrosine Kinase Inhibitor: A potential treatment for SARS- COV-2 induced pneumonia. Alexandria Journal of Medicine, 56(1), 68–72. https://doi.org/10.1080/20905068.2020.1778417
   Web of Science ®Google Scholar
• Bibi, N., Gul, S., Ali, J., & Kamal, M. A. (2020). Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. European Journal of Pharmacology, 885, 173496. https://doi.org/10.1016/j.ejphar.2020.173496
   PubMed Web of Science ®Google Scholar
• Bouvet, M., Lugari, A., Posthuma, C. C., Zevenhoven, J. C., Bernard, S., Betzi, S., Imbert, I., Canard, B., Guillemot, J. C., Lécine, P., Pfefferle, S., Drosten, C., Snijder, E. J., Decroly, E., & Morelli, X. (2014). Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. The Journal of Biological Chemistry, 289(37), 25783–25796. 12https://doi.org/10.1074/jbc.M114.577353
   PubMed Web of Science ®Google Scholar
• Chan, J. F., Chik, K. K., Yuan, S., Yip, C. C., Zhu, Z., Tee, K. M., Tsang, J. O., Chan, C. C., Poon, V. K., Lu, G., Zhang, A. J., Lai, K. K., Chan, K. H., Kao, R. Y., & Yuen, K. Y. (2017). Novel antiviral activity and mechanism of Bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Research, 141, 29–37. https://doi.org/10.1016/j.antiviral.2017.02.002 (2017).
   PubMed Web of Science ®Google Scholar
• Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Medicine, 3(8), 866–871. https://doi.org/10.1038/nm0897-866
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.), 1263, 243–250.
   PubMedGoogle Scholar
• DeFronzo, R. A. (2011). Bromocriptine: A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care, 34(4), 789–794. https://doi.org/10.2337/dc11-0064
   PubMed Web of Science ®Google Scholar
• Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jr, Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893. https://doi.org/10.1128/AAC.03036-14
   PubMed Web of Science ®Google Scholar
• Egloff, M. P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E. J., Gorbalenya, A. E., Cambillau, C., & Canard, B. (2004). The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proceedings of the National Academy of Sciences of the United States of America, 101(11), 3792–3796. https://doi.org/10.1073/pnas.0307877101
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/10.1063/1.470117
   Web of Science ®Google Scholar
• Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., Yang, X., … Rao, Z. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science (New York, N.Y.), 368(6492), 779–782. https://doi.org/10.1126/science.abb7498
   PubMed Web of Science ®Google Scholar
• Garson, J. A., Lubach, D., Passas, J., Whitby, K., & Grant, P. R. (1999). Suramin blocks hepatitis C binding to human hepatoma cells in vitro. Journal of Medical Virology, 57(3), 238–242. https://doi.org/10.1002/(SICI)1096-9071(199903)57:
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Iqbal, N., & Iqbal, N. (2014). Imatinib: A breakthrough of targeted therapy in cancer. Chemotherapy Research and Practice, 2014, 357027. https://doi.org/10.1155/2014/357027
   PubMedGoogle Scholar
• Jang, K. J., Jeong, S., Kang, D. Y., Sp, N., Yang, Y. M., & Kim, D. E. (2020). A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA. Scientific Reports, 10(1), 4481. https://doi.org/10.1038/s41598-020-61432-1
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Yin, W., & Xu, H. E. (2021). RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochemical and Biophysical Research Communications, 538, 47–53. S0006-291X(20)31721-31726)https://doi.org/10.1016/j.bbrc.2020.08.116
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. Junehttps://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., Tang, X., Yu, J., Lan, J., Yuan, J., Wang, H., Zhao, J., Zhang, S., Wang, Y., Shi, X., … Zhang, L. (2020). Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature, 584(7819), 115–119. https://doi.org/10.1038/s41586-020-2380-z
   PubMed Web of Science ®Google Scholar
• Kato, F., Ishida, Y., Oishi, S., Fujii, N., Watanabe, S., Vasudevan, S. G., Tajima, S., Takasaki, T., Suzuki, Y., Ichiyama, K., Yamamoto, N., Yoshii, K., Takashima, I., Kobayashi, T., Miura, T., Igarashi, T., & Hishiki, T. (2016). Novel antiviral activity of Bromocriptine against dengue virus replication. Antiviral Research, 131, 141–147. https://doi.org/10.1016/j.antiviral.2016.04.014
   PubMed Web of Science ®Google Scholar
• Mousavizadeh, L., & Ghasemi, S. (2021). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology, and Infection = Wei Mian yu Gan Ran za Zhi, 54(2), 159–163. https://doi.org/10.1016/j.jmii.2020.03.022
   PubMedGoogle Scholar
• Numazaki, K. (2003). Glycyrrhizin therapy for viral infections. African Journal of Biotechnology, 2(10), 392–393.
   Google Scholar
• Offensperger, W. B., Offensperger, S., Walter, E., Blum, H. E., & Gerok, W. (1993). Suramin prevents duck hepatitis B virus infection in vivo. Antimicrobial Agents and Chemotherapy, 37(7), 1539–1542. https://doi.org/10.1128/aac.37.7.1539
   PubMed Web of Science ®Google Scholar
• Pazel, D. P. (1989). DS-Viewer- interactive graphical data structure presentation facility. IBM Systems Journal, 28(2), 307–323. in https://doi.org/10.1147/sj.282.0307
   Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Rosas-Lemus, M., Minasov, G., Shuvalova, L., Inniss, N. L., Kiryukhina, O., Wiersum, G., Kim, Y., Jedrzejczak, R., Maltseva, N. I., Endres, M., Jaroszewski, L., Godzik, A., Joachimiak, A., & Satchell, K. (2020). The crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine. bioRxiv: the preprint server for biology. https://doi.org/10.1101/2020.04.17.047498
   Google Scholar
• Schmid, N., Eichenberger, A., Choutko, A., Riniker, S., Winger, M., Mark, A., & van Gunsteren, W. (2011). Definition and testing of the GROMOS force-field versions 54A7 and 54B7. European Biophysics Journal : EBJ, 40(7), 843–856. https://doi.org/10.1007/s00249-011-0700-9
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91–98. https://doi.org/10.1016/j.jare.2020.03.005
   PubMed Web of Science ®Google Scholar
• Shyr, Z. A., Gorshkov, K., Chen, C. Z., & Zheng, W. (2020). Drug discovery strategies for SARS-CoV-2. The Journal of Pharmacology and Experimental Therapeutics, 375(1), 127–138. https://doi.org/10.1124/jpet.120.000123
   PubMed Web of Science ®Google Scholar
• StatPearls. (2021). Features, Evaluation and Treatment Coronavirus (COVID19). https://www.ncbi.nlm.nih.gov/books/NBK554776/.
   Google Scholar
• Stobart, C. C., Sexton, N. R., Munjal, H., Lu, X., Molland, K. L., Tomar, S., Mesecar, A. D., & Denison, M. R. (2013). Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity. Journal of Virology, 87(23), 12611–12618. https://doi.org/10.1128/JVI.02050-13
   PubMed Web of Science ®Google Scholar
• Te Velthuis, A. J., van den Worm, S. H., & Snijder, E. J. (2012). The SARS-coronavirus nsp7 + nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Research, 40(4), 1737–1747. https://doi.org/10.1093/nar/gkr893
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Walsh, I., Minervini, G., Corazza, A., Esposito, G., Tosatto, S. C. E., & Fogolari, F. (2012). Bluues server: Electrostatic properties of wild-type and mutated protein structures. Bioinformatics (Oxford, England), 28(16), 2189–2190. Pages https://doi.org/10.1093/bioinformatics/bts343
   PubMed Web of Science ®Google Scholar
• Wang, H., Xue, S., Yang, H., & Chen, C. (2016). Recent progress in the discovery of inhibitors targeting coronavirus proteases. Virologica Sinica, 31(1), 24–30. https://doi.org/10.1007/s12250-015-3711-3
   PubMed Web of Science ®Google Scholar
• Weisberg, E., Parent, A., Yang, P. L., Sattler, M., Liu, Q., Liu, Q., Wang, J., Meng, C., Buhrlage, S. J., Gray, N., & Griffin, J. D. (2020). Repurposing of kinase inhibitors for treatment of COVID-19. Pharmaceutical Research, 37(9), 167 https://doi.org/10.1007/s11095-020-02851-7
   PubMed Web of Science ®Google Scholar
• Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.), 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Yang, Y., Peng, F., Wang, R., Yange, M., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. (2020). The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity, 109, 102434–102434. https://doi.org/10.1016/j.jaut.2020.102434
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., & Huang, C.-L. (2020). Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv, 2020.01.22.914952.
   Google Scholar